Last reviewed · How we verify
Anti-PDL-1 antibody
At a glance
| Generic name | Anti-PDL-1 antibody |
|---|---|
| Also known as | BMS-936559, MDX 1105 |
| Sponsor | Bristol-Myers Squibb |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-PDL-1 antibody CI brief — competitive landscape report
- Anti-PDL-1 antibody updates RSS · CI watch RSS
- Bristol-Myers Squibb portfolio CI